Sign in

NCT07922317Recruiting

ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window

Evaluation of Clinical Outcomes Following Endovascular Thrombectomy for Acute Ischemic Stroke With Anterior Large Vessel Occlusion in Extended Time Window (24-72 Hours)

Source: ClinicalTrials.gov · Last updated 6 Nov 2026

Brief summary (registry, in English)

The ELATE study is a prospective, observational study designed to evaluate the clinical outcomes and safety profile of endovascular thrombectomy compared with best medical treatment alone in patients presenting with acute ischemic stroke due to anterior large vessel occlusion within 24 to 72 hours from stroke onset or last known well.

Status (registry)
Recruiting
Study type
Observational
Enrollment
284 (estimated)
First submitted
2 Nov 2026
Start date
6 Jul 2026
Primary completion date
31 Dec 2028
Lead sponsor
115 People's Hospital
Diseases
Stroke
NCT number
NCT07922317

What you commit to

  • Study type: Observational
  • Planned participants: 284
  • From 6 Jul 2026 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pre-stroke modified Rankin Score (mRS) score of >2 (indicating previous disability)

Other illness

  • Intracranial hemorrhage identified by CT or MRI
  • Any terminal illness such that the patient has a life expectance of less than 1 year.
  • Patients with active cancer and undergoing treatment for cancer are excluded

Other

  • Pregnancy

Who the study is looking for

  • Age ≥ 18 years
  • Presentation with acute ischemic stroke within 24 to 72 hours of stroke onset or last known well.
  • Baseline NIHSS ≥ 8 (If patients have NIHSS < 8 at admission and experienced END to an NIHSS score ≥ 8 or higher, they also were included if they were 24 to 72 hours from the LKW at this point)
  • Clinical diagnosis of AIS due to anterior circulation LVO (internal carotid artery (ICA) extracranial or intracranial segment, middle cerebral artery (MCA) M1 and proximal M2 segment) on brain imaging (CTA/MRA).
  • Imaging criteria: must fulfill at least one:
    • 1) Core-penumbra mismatch on CT perfusion (CTP) or MR perfusion (MRP) assessed: infarct core volume ≤ 70mL, mismatch ratio ≥ 1,8 and mismatch volume ≥ 15mL.
    • 2) ASPECTS ≥6 on non-contrast CT or diffusion-weighted imaging (DWI).
  • Written informed consent (by patient or proxy, according to local requirements)

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
115 PEOPLE's HOSPITAL
Coordinator of this site? Confirm its status
Ho Chi Minh CityVietnamRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.